These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 26637952)

  • 1. Clonidine complexation with hydroxypropyl-beta-cyclodextrin: From physico-chemical characterization to in vivo adjuvant effect in local anesthesia.
    Braga MA; Martini MF; Pickholz M; Yokaichiya F; Franco MK; Cabeça LF; Guilherme VA; Silva CM; Limia CE; de Paula E
    J Pharm Biomed Anal; 2016 Feb; 119():27-36. PubMed ID: 26637952
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development and pharmacological evaluation of ropivacaine-2-hydroxypropyl-beta-cyclodextrin inclusion complex.
    de Araujo DR; Tsuneda SS; Cereda CM; Del G F Carvalho F; Preté PS; Fernandes SA; Yokaichiya F; Franco MK; Mazzaro I; Fraceto LF; de F A Braga A; de Paula E
    Eur J Pharm Sci; 2008 Jan; 33(1):60-71. PubMed ID: 18036789
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Complexation of oxethazaine with 2-hydroxypropyl-β-cyclodextrin: increased drug solubility, decreased cytotoxicity and analgesia at inflamed tissues.
    Prado AR; Yokaichiya F; Franco MKKD; Silva CMGD; Oliveira-Nascimento L; Franz-Montan M; Volpato MC; Cabeça LF; de Paula E
    J Pharm Pharmacol; 2017 Jun; 69(6):652-662. PubMed ID: 28211640
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Improvement of tetracaine antinociceptive effect by inclusion in cyclodextrins.
    Franco de Lima RA; de Jesus MB; Saia Cereda CM; Tofoli GR; Cabeça LF; Mazzaro I; Fraceto LF; de Paula E
    J Drug Target; 2012 Jan; 20(1):85-96. PubMed ID: 22047178
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preparation and characterization of simvastatin/hydroxypropyl-beta-cyclodextrin inclusion complex using supercritical antisolvent (SAS) process.
    Jun SW; Kim MS; Kim JS; Park HJ; Lee S; Woo JS; Hwang SJ
    Eur J Pharm Biopharm; 2007 Jun; 66(3):413-21. PubMed ID: 17240129
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Elucidation of the orientation of selected drugs with 2-hydroxylpropyl-β-cyclodextrin using 2D-NMR spectroscopy and molecular modeling.
    Adhikari S; Daftardar S; Fratev F; Rivera M; Sirimulla S; Alexander K; Boddu SHS
    Int J Pharm; 2018 Jul; 545(1-2):357-365. PubMed ID: 29747001
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sufentanil-2-hydroxypropyl-β-cyclodextrin inclusion complex for pain treatment: physicochemical, cytotoxicity, and pharmacological evaluation.
    Volobuef C; Moraes CM; Nunes LA; Cereda CM; Yokaichiya F; Franco MK; Braga AF; De Paula E; Tófoli GR; Fraceto LF; De Araujo DR
    J Pharm Sci; 2012 Oct; 101(10):3698-707. PubMed ID: 22736497
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inclusion complex of colchicine in hydroxypropyl-β-cyclodextrin tenders better solubility and improved pharmacokinetics.
    Chauhan R; Madan J; Kaushik D; Sardana S; Pandey RS; Sharma R
    Pharm Dev Technol; 2013; 18(2):313-22. PubMed ID: 21699389
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preparation, characterization, pharmacokinetics, and bioactivity of honokiol-in-hydroxypropyl-β-cyclodextrin-in-liposome.
    Wang X; Deng L; Cai L; Zhang X; Zheng H; Deng C; Duan X; Zhao X; Wei Y; Chen L
    J Pharm Sci; 2011 Aug; 100(8):3357-3364. PubMed ID: 21387317
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inclusion complexes of chlorzoxazone with β- and hydroxypropyl-β-cyclodextrin: Characterization, dissolution, and cytotoxicity.
    Tang P; Li S; Wang L; Yang H; Yan J; Li H
    Carbohydr Polym; 2015 Oct; 131():297-305. PubMed ID: 26256188
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Controlled systemic absorption and increased anesthetic effect of bupivacaine following epidural administration of bupivacaine-hydroxypropyl-beta-cyclodextrin complex.
    Fréville JC; Dollo G; Le Corre P; Chevanne F; Le Verge R
    Pharm Res; 1996 Oct; 13(10):1576-80. PubMed ID: 8899854
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Posaconazole/hydroxypropyl-β-cyclodextrin host-guest system: Improving dissolution while maintaining antifungal activity.
    Tang P; Ma X; Wu D; Li S; Xu K; Tang B; Li H
    Carbohydr Polym; 2016 May; 142():16-23. PubMed ID: 26917368
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Study of the interaction between S(--) bupivacaine and 2-hydroxypropyl-beta-cyclodextrin.
    Moraes CM; Abrami P; de Paula E; Braga AF; Fraceto LF
    Int J Pharm; 2007 Feb; 331(1):99-106. PubMed ID: 17071028
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preparation and solid-state characterization of bupivacaine hydrochloride cyclodextrin complexes aimed for buccal delivery.
    Jug M; Maestrelli F; Bragagni M; Mura P
    J Pharm Biomed Anal; 2010 May; 52(1):9-18. PubMed ID: 20004541
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preparation, characterization and in vivo evaluation of formulation of repaglinide with hydroxypropyl-β-cyclodextrin.
    Liu M; Cao W; Sun Y; He Z
    Int J Pharm; 2014 Dec; 477(1-2):159-66. PubMed ID: 25455768
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inclusion complex of barbigerone with hydroxypropyl-β-cyclodextrin: preparation and in vitro evaluation.
    Qiu N; Cheng X; Wang G; Wang W; Wen J; Zhang Y; Song H; Ma L; Wei Y; Peng A; Chen L
    Carbohydr Polym; 2014 Jan; 101():623-30. PubMed ID: 24299819
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Investigation of inclusion complex of cilnidipine with hydroxypropyl-β-cyclodextrin.
    Hu L; Zhang H; Song W; Gu D; Hu Q
    Carbohydr Polym; 2012 Nov; 90(4):1719-24. PubMed ID: 22944438
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preparation and characterization of hydroxypropyl-β-cyclodextrin inclusion complex of eugenol: differential pulse voltammetry and (1)H-NMR.
    Garg A; Gupta B; Prakash R; Singh S
    Chem Pharm Bull (Tokyo); 2010 Oct; 58(10):1313-9. PubMed ID: 20930396
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular simulation of hydroxypropyl-beta-cyclodextrin with hydrophobic selective Cox-II chemopreventive agent using host-guest phenomena.
    Sinha VR; Nanda A; Chadha R; Goel H
    Acta Pol Pharm; 2011; 68(4):585-92. PubMed ID: 21796941
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis and evaluation of a novel β-cyclodextrin derivative for oral insulin delivery and absorption.
    Zhang L; Zhang Z; Li N; Wang N; Wang Y; Tang S; Xu L; Ren Y
    Int J Biol Macromol; 2013 Oct; 61():494-500. PubMed ID: 23994793
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.